Publication | Closed Access

Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain

InflammationToll-like ReceptorsNeuroinflammationAnti-inflammatoryPain MedicineMedicineImmunologyMolecular PainAttenuates Neuropathic PainBrain-immune InteractionPain MechanismPharmacologyToll-like Receptor 4NeuroimmunologyPain Research